CoreX Abu Dhabi

CoreX | Sovereign Bio-Intelligence Rewriting the future of pharma from the world’s most visionary nation. CoreX is the UAE’s sovereign biotech platform — building the world’s first end-to-end AI-powered drug development engine. Powered by organoid avatars, IPSC technology, and a proprietary BioLLM trained on real biology, CoreX is replacing outdated clinical trials with predictive, population-aware science. From molecule discovery to pharmacoequity validation, CoreX integrates: • Biological AI that learns from patient-derived organoids. • A Population Library that ensures every drug is tested across real-world demographics. • A new Pharma Sovereignty Model where nations lead innovation, data ownership, and regulatory validation. Backed by Quris and born in Abu Dhabi, CoreX partners with governments, pharma, and investors to: • Accelerate safer, personalized, and inclusive drug development • Monetize data and biological IP at national scale • Create new revenue models from generics, repurposed drugs, and platform licensing Built by and for sovereign health systems. Designed to serve 8 billion.